Artisan Partners Limited Partnership Ascendis Pharma A/S Transaction History
Artisan Partners Limited Partnership
- $62.4 Billion
- Q4 2024
A detailed history of Artisan Partners Limited Partnership transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Artisan Partners Limited Partnership holds 4,450,420 shares of ASND stock, worth $695 Million. This represents 0.98% of its overall portfolio holdings.
Number of Shares
4,450,420
Previous 4,411,111
0.89%
Holding current value
$695 Million
Previous $659 Million
6.99%
% of portfolio
0.98%
Previous 1.03%
Shares
27 transactions
Others Institutions Holding ASND
# of Institutions
236Shares Held
60.2MCall Options Held
80.3KPut Options Held
216K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.58 Billion22.55% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.53MShares$863 Million3.52% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.1MShares$797 Million10.24% of portfolio
-
Janus Henderson Group PLC London, X04.38MShares$684 Million0.32% of portfolio
-
Capital International Investors Los Angeles, CA2.86MShares$447 Million0.08% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $8.72B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...